| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |